key: cord-0861340-9s77hwnt
authors: Gilligan, Peter H.
title: Diarrheal disease and DRGs
date: 1986-01-01
journal: Clinical Microbiology Newsletter
DOI: 10.1016/0196-4399(86)90096-6
sha: ca105be65dffffd6e0e5b402d45d1e6394161a8d
doc_id: 861340
cord_uid: 9s77hwnt

Abstract This article has presented a rational protocol for examining stools for enteric pathogens. When modified according to a laboratory's geographical location and patient population, this approach should allow efficient, comprehensive diagnosis of diarrheal disease. Laboratories should be able to examine stools routinely for Campylobacter spp., Salmonella spp., Shigella spp., Y. enterocolitica, intestinal parasites [including Cryptosporidium (14)], rotavirus, and C. difficile toxin. When unusual organisms such as pathogenic E. coli are suspected, or tissue culture facilities for C. difficile toxin assays are unavailable, the use of reference laboratories is strongly encouraged.

Current regulations, by which reimbursement is based on diagnosis related groups (DRGs), are changing clinical laboratories from revenue producing centers to cost centers (25). This transition is happening at the same time as a dramatic increase in our knowledge of infectious diseases, including new understanding of the etiology of diarrhea1 disease. Ten years ago, the etiology of enteric disease in many patients was unknown because stool specimens were routinely screened only for Salmonella spp., Shigella spp., and perhaps intestinal parasites such as Giardia lamblia. At present, many laboratories also routinely examine stool specimens for Campylobacter spp., Yersinia entero-colitica, Clostridiutn difficile, Cryptosporidium, and rotavirus. Aeromonas spp. (l), Vibrio spp. (4, 5), strains of Escherichia coli (6, (17) (18) (19) , Norwalk agent, enteric adenoviruses, coronaviruses, and caliciviruses (8) have also been suggested as causes of diarrhea1 disease; food poisoning agents such as Staphylococcus aureus and Bacillus cereus must also be considered. Faced with declining resources and expanding knowledge, what approaches should be taken to provide efficient, yet comprehensive, diagnostic services to patients with diarrhea1 disease?

To adequately address this question, retrospective review of laboratory results is needed to determine which agents are the ones most likely to cause diarrhea1 disease in a particular patient population. Table 1 lists data on the frequency with which we detected enteric pathogens during the past 3 yr at our 600-bed hospital. These data were obtained by culturing approximately 10,000 patients for Her areas of special research interest are antimicrobial susceptibility testing and applications of DNA probes to clinical microbiology. Her input into these, as well as other areas of clinical microbiology, will help to maintain the Newsletter as a current and high quality publication. 

Not all stool specimens should be examined routinely for all agents listed in Table 1 . For the most efficient use of laboratory facilities, as well as maximum benefit to the patient, a selective examination process must be followed based on factors such as patient age and history, as well as the clinical microbiologist's understanding of the pathogenesis and local epidemiology of diarrhea1 disease. Figure 1 presents an algorithm that can be used as a guideline to determine how to examine stool specimens from different patient populations. This algorithm divides patients according to age, whether those older than 3 yr are inpatients or outpatients, and whether they have received antimicrobial agents or cancer chemotherapeutics. Stools from patients who have currently or recently received antimicrobial agents or cancer chemotherapeutics should be examined only for C. d@cile toxin because studies have shown that, in such patients, other enteric pathogens are rarely, if ever, present (9). Tests for detecting C. di'cile toxin must be done instead of culture because up to 20% of people receiving antimicrobial agents are asymptomatic carriers of the organism (24). On the other hand, only 2% of patients have toxin in the absence of symptoms. Toxin is detected in the feces of approximately 30% of patients with antimicrobial agent-associated diarrhea and essentially all patients with pseudomembranous colitis (3). Tissue culture assay remains the standard test for toxin detection. Alternative methods such as counterimmunoelectrophoresis ( 12) and latex agglutination (2 I) lack sufficient sensitivity and specificity; ELISA tests (13), although accurate, are not yet widely available.

Stools from inpatients who are not receiving antimicrobial therapy usually are negative for enteric pathogens. Because nosocomial outbreaks of Salmonella and Shigella have occurred (10, 16), stool specimens may be screened for these agents. In certain areas of the United States where Giardia is endemic, e.g., Colorado (1 I), stools from patients with appropriate signs and symptoms may be examined for this protozoan.

Patients with acquired immune deficiency syndrome (AIDS) present a special challenge because diarrhea can be a frequent, potentially lifethreatening illness. Cryptosporidium, Salmonella, Shigella, and Giardia are commonly associated with this syndrome (10). The diagnosis of C. diffitile enterocolitis must also be considered because these patients may receive a variety of antimicrobial agents to treat their opportunistic infections.

Outpatients with diarrhea1 disease present a greater challenge than inpatients because they can be infected by a large variety of microbial agents. Rational strategies for evaluating these patients can be developed by carefully noting their travel and food history. Stool examinations should not be performed unless the patient has been symptomatic for at least 3 days. In this way, persons with self-limited disease will be spared the expense of the culture, an especially important factor in health maintenance organizations (HMOs). Stools from patients with persistent symptoms should be cultured for Salmonella, Shigella, and Campylobacter, as well as examined for intestinal parasites, which may be found almost as commonly as bacterial pathogens (Table I) .

The complete stool work-up should include two cultures for bacteria and three examinations for parasites. Specimen collection should be spaced so that the examinations can be completed before another stool analysis is performed. If the tests are negative and the patient remains symptomatic, a search for "unusual" agents of diar-rhea1 disease should be made, e.g., in patients with bloody diarrhea, strains of E. coli that cause hemorrhagic colitis (17). Such isolates are usually identified in reference laboratories by a combination of biochemical tests, serotyping, and ability to produce a Shigalike toxin (15). State health laboratories should be contacted about their ability to process specimens to detect these, as well as other, pathogenic E.

The stools of patients who have either a history of travel to undeveloped countries or of ingestion of raw seafoods, should be examined for Vibrio spp. and enterotoxigenic E. coli. Vibrios can be cultured on TCBS agar, but specimens for enterotoxigenic E. coli should be sent to a reference labo- ratory. During the summer months in particular, stools from symptomatic individuals living along the Gulf of Mexico should also be screened for vibrios (4).

In patients with chronic diarrhea, whose routine stool examinations are negative, the following etiologies should be considered: Ctytosporidium in immunocompetent individuals (2). C. dijjicile toxin in patients with a history of antibiotic therapy within the past 4 weeks, and Giurdia. Giardia may not be detected by repeated stool examination, and therefore the parasite should be sought either in duodenal biopsy material or duodenal fluid.

Most enteric pathogens are detected in neonates and infants up to 3-yr old. The epidemiology of disease in this patient population greatly influences the diagnostic approach. In temperate zones of the Northern Hemisphere, from December to March, rotavirus is the most important cause of diarrhea1 disease in young children (8). For diagnosis, a rotavirus ELISA test is usually the first step because the results are often available within 24 hr. The specimen can be refrigerated and further tests deferred until the rotavirus test result is known. If the test is negative, the fecal screen outlined previ-ously can be performed. If symptoms persist for more than 5 days in rotavirus-positive patients, a stool specimen should be examined for other pathogens. Pathogens such as calicivirus and coronavirus produce disease it can be identified in a reference laboratory by its adherence to HEP-2 cells (6). Enteroadherent E. co/i are associated with failure-to-thrive syndrome and nursery outbreaks of diarrhea1 disease (18).

The role of C. d$ficile diarrhea1 disease in children less than 3-yr old is unclear. Some investigators believe that this organism is normal flora in neonates and that toxin can be present in feces without accompanying disease. Others, however, have associated C. difJicile with chronic diarrhea and failure-to-thrive syndrome (23).

The age at which children can develop antimicrobial agent-induced diarrhea and colitis requires clarification. Stark and Lee (22) suggest that the organism is normal flora for at least 9 months. In children younger than 3-yr old, the Y. enterocolifica is frequently isolated from children. Although selective media and special culture condi-diagnosis of C. difficile-associated distions may be used to enhance its re-ease should be based on strong evi- 

The possibility of a food-borne outbreak should be considered when diagnosing diarrhea1 disease. In most instances outbreaks are limited to small numbers of people and the disease is mild and self-limited. Some outbreaks, however, are widespread, affect hundreds to thousands of individuals, and have potentially high morbidity and mortality. Clinical microbiologists, in conjunction with their infectious disease colleagues, should evaluate unusual patterns of recovery of enteric pathogens. For example, this past summer one of our technologists, working with our pediatric infectious disease physicians, helped to uncover an outbreak of shigellosis which occurred after a family reunion. Nine family members had stool cultures positive for Shigella. By working with public health officials, we were able to contain the outbreak to this single family.

This article has presented a rational protocol for examining stools for enteric pathogens. When modified according to a laboratory's geographical location and patient population, this approach should allow efficient, comprehensive diagnosis of diarrhea1 disease. Laboratories should be able to examine stools routinely for Campylobatter spp., Salmonella spp., Shigella spp., Y. enterocolitica, intestinal parasites [including Cryptosporidium (1411, rotavirus, and C. di$icile toxin. When unusual organisms such as pathogenic E. coli are suspected, or tissue culture facilities for C. di#icile toxin assays are unavailable, the use of reference laboratories is strongly encouraged.

Clinical and microbiological features of Aero-rnon~~ hydrophila-associated diarrhea

Cryptosporidia in a healthy professional athlete

Colitis induced by Clostridium d@icile

Vibrios on the half shell: what the walrus and carpenter didn't know

Spectrum of Vibrio infections in a Gulf Coast community

Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli

Clostridium dijjicile colitis associated with cancer chemotherapy

Relative frequency of Clostridium dlficile in patients with diarrhea1 disease

Outbreak of Shigella sonnei dysentery on a geriatric assessment ward

Waterborne giardiasis at a mountain resort: evidence for acquired immunity

Use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation

Enzyme immunoassays for detection of

srridium difficrlr toxins A and B in fecal specimens

Threestep stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea

Production of Shigella dysenreriae type I-like cytotoxin by Escherichia coli

Investigation of outbreaks of Salmonella in hospitals

Sporadic cases of hemorrhagic colitis associated with Escherichia co/i 0157:Hl

A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants

The role of Escherichia coli in gastroenteritis

Synthesis of a selective agar medium for Yersinia enterocolirica

Latex agglutination test for detection of Closrridium d@cile toxin in stool samples

Clostridia isolated from the feces of infants during the first year of life

Chronic diarrhea associated with Clostridium d@cile in children

198 1. Isolation rates and toxigenic potential of Closrridium d@?-tile isolates from various patient populations

The clinical microbiology laboratory: utilization and cost effectiveness